Jefferies Lilfts Price Target on BioMarin (BMRN)

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/30/2026

1. SPY
2. EOSE
3. DLR
4. AVAV
5. MU
6. ENPH
7. ABVX
8. BAC
9. NVDA
10. VSH

July 29, 2011 11:50 AM EDT
Get Alerts BMRN Hot Sheet
Price: $56.76 -1.58%

Rating Summary:
    25 Buy, 10 Hold, 0 Sell

Rating Trend: = Flat

Today's Overall Ratings:
    Up: 14 | Down: 19 | New: 18
Join SI Premium – FREE
Jefferies raised its price target on BioMarin Pharmaceutical Inc. (NASDAQ: BMRN) from $33 to $35 while maintaining a Buy rating.

The firm comments, "Reported ~3-5% higher 2Q11 revenue of $110.6M (vs. our/cons estimates of $107.0M/$105.3M) on higher Naglazyme sales; /GALNS Ph2 extension data for additional 24 weeks shows sustained benefits for ~2 years, with Ph3 data release on track for 2H12. On increased probability for GALNS, we are raising our PT to $35 from $33."

For more ratings news on BioMarin Pharmaceutical Inc. click here and for the rating history of BioMarin Pharmaceutical Inc. click here.

Shares of BioMarin Pharmaceutical Inc. closed at $29.29 yesterday.

Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In





Related Categories

Analyst Comments

Related Entities

Jefferies & Co